About this blog
one daze is no better than the previous…
Lilly Receives FDA Approval to Expand the Use of Cymbalta
INDIANAPOLIS, Nov. 4, 2010 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of chronic musculoskeletal pain. This has been established in studies in patients with chronic low back pain and chronic pain due to osteoarthritis. This is the fifth indication the FDA has approved for Cymbalta.
Lilly and Me.
In 2004 Eli Lilly announced the global launch of Cymbalta (Duloxetine) for treatment of "major depressive disorder" and "diabetic peripheral neuropathic pain". From 2004 until December 31, 2009, Lilly have accumulated $9,964,700,000 (USD) of sales in Cymbalta.
Cymbalta and Adderall both affect neurotransmitters and were prescribed to me to treat the symptoms of ADHD. After taking this stuff for more than a year, accompanied by its variety of side-effects but without a commensurate net gain, I elected to stop taking both medications. I notified my attending physician that weaning off the meds might be required and that I would need for him to issue the appropriate prescription to the neighbourhood pharmacy that he'd been issuing previous prescriptions for the prior year. He did not.
The experience of withdrawal from Cymbalta continues to be the most harrowing, soul-retching experiences of my fifty-seven, storied years. There are a multitude of forums around the internet with heart-rendering pleas from people affected by their attempts to stop taking this crap. Many of us remain concerned that whatever changes have been effected by this drug are chronic and perhaps, permanent.
Suicide ideation is a common theme amongst us. This is dark and gets worse; loved ones of those who have committed suicide are also voicing their astonishment that Lilly is permitted to continue marketing this inherently evil drug. Yes, this get worse too since on November 3, 2010 Lilly were granted FDA approval to expand the use of Cymbalta to another indication.
This blog provides an outlet for my continuing struggle to regain a reasonably healthy nervous system and it might, in turn, provide an empathic voice for others with their own "discontinuation" horror. The truth is, there isn't anyone, regardless of the amount of love, care and dedication they bring to us, who can appreciate what kind of ride Cymbalta withdrawal can be.
Lilly provides its sales force with a business plan to guide and optimize the distribution process. The immediate customer base for these sales reps are general practitioners, neural clinicians and psychiatric specialists; the public's primary and secondary health care providers.
The sales tutorial guides the reps on educating doctors to replace references to the nasty, sometimes deadly Cymbalta withdrawal with the term "discontinuation syndrome".
Marketing spin doesn't belong in the relationship between a physician and patient. The ethical considerations reach back to the fourth century when new doctors were required to swear an oath indicating that they would do no harm.
Now we see a disturbing, hierarchical relationship where physicians act as local dealers for drug producers and exploit the trust between themselves and their patients for for the sake of business; it can't possibly be for the benefit of the patients. The hard-earned sense of integrity has been compromised and contaminated by greed. It seems the "...do no harm" part of the Hippocratic Oath has been re-engineered to mean "don't harm the bottom line with annoying issues like truth".
Eli Lilly is a publicly-traded, multi-national corporation. In Western culture the corporation is accountable to the shareholders, not to customers. Lilly is in business to make money, not save lives. Any benevolent spin associated with a public corporation is intended to serve the purpose of creating or enhancing an image so to facilitate the creation of wealth.
Nothing wrong with this, per se...it's a reality of the capitalistic engine that is part of what keeps our standard of living high and comfortable. Of course checks and balances are rightfully expected to be provided by legislators and by the integrity of the medical community. Seems like we're missing a couple of key ingredients.